追蹤
Dr Puneet Utreja
Dr Puneet Utreja
Director Cum Principal, PCTE Group of Institutes, Ludhiana
在 pcte.edu.in 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
Elastic Liposomal Formulation for Sustained Delivery of Colchicine: In Vitro Characterization and In Vivo Evaluation of Anti-gout Activity
HP Singh, P Utreja, AK Tiwary, S Jain
The AAPS journal 11, 54-64, 2009
1132009
Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects
P Utreja, S Jain, A K Tiwary
Current Drug Delivery 7 (2), 152-161, 2010
912010
Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy
S Verma, P Utreja
Asian journal of pharmaceutical sciences 14 (2), 117-129, 2019
882019
Advanced drug delivery systems for transdermal delivery of non-steroidal anti-inflammatory drugs: a review
L Kumar, S Verma, M Singh, T Chalotra, P Utreja
Current drug delivery 15 (8), 1087-1099, 2018
882018
An overview of therapeutic effects of vanillic acid
N Sharma, N Tiwari, M Vyas, N Khurana, A Muthuraman, P Utreja
Plant Arch 20 (2), 3053-3059, 2020
762020
Poly propyl ether imine (PETIM) dendrimer: A novel non-toxic dendrimer for sustained drug delivery
S Jain, A Kaur, R Puri, P Utreja, A Jain, M Bhide, R Ratnam, V Singh, ...
European journal of medicinal chemistry 45 (11), 4997-5005, 2010
712010
Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation
P Utreja, S Jain, AK Tiwary
Drug Delivery 18 (5), 367-376, 2011
532011
Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation
P Utreja, S Jain, AK Tiwary
Drug delivery 19 (1), 11-20, 2012
372012
Transethosomes of econazole nitrate for transdermal delivery: Development, in-vitro characterization, and ex-vivo assessment
S Verma, P Utreja
Pharmaceutical Nanotechnology 6 (3), 171-179, 2018
342018
Formulation and characterization of transethosomes for enhanced transdermal delivery of propranolol hydrochloride
L Kumar, P Utreja
Micro and nanosystems 12 (1), 38-47, 2020
332020
Use of nanoparticles in medicine
P Utreja, S Verma, M Rahman, L Kumar
Current Biochemical Engineering 6 (1), 7-24, 2020
262020
Paclitaxel loaded nanoliposomes in thermosensitive hydrogel: A dual approach for sustained and localized delivery
M Mahajan, P Utreja, S Kumar Jain
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016
252016
Recent advances in drug delivery systems for anti-diabetic drugs: a review
M Grover, P Utreja
Current Drug Delivery 11 (4), 444-457, 2014
232014
Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities
L Kumar, S Verma, K Joshi, P Utreja, S Sharma
Future Journal of Pharmaceutical Sciences 7 (1), 175, 2021
212021
Nanotechnological carriers for treatment of acne
S Verma, P Utreja, L Kumar
Recent patents on anti-infective drug discovery 13 (2), 105-126, 2018
212018
Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation
P Utreja, S Jain, S Yadav, K L Khandhuja, A K Tiwary
Current drug safety 6 (5), 329-338, 2011
192011
Nanostructured lipid carriers and their application in drug delivery
S Khurana, P Utreja, AK Tiwary, NK Jain, S Jain
International Journal of Biomedical Engineering and Technology 2 (2), 152-171, 2009
192009
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model
N Sharma, N Khurana, A Muthuraman, P Utreja
European Journal of Pharmacology 903, 174112, 2021
182021
Elastic liposomal formulation for sustained delivery of colchicine
HP Singh, P Utreja, AK Tiwary, S Jain
in vitro characterization and in vivo evaluation of anti-gout activity 2009, 11, 0
14
Gold nanoparticles and their applications in cancer treatment
S Verma, P Utreja, M Rahman, L Kumar
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 8 (3), 184-201, 2018
132018
系統目前無法執行作業,請稍後再試。
文章 1–20